{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Changed the "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Anlaysis_Essay.docx', 'Anlaysis_Essay.pdf', 'Pfizer']"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "os.chdir('/Users/arihantchoudhary/GitHub/Klarity/uploads')\n",
    "os.getcwd()\n",
    "os.listdir()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Importing Document Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Pfizer dataset is in uploads folder, it has a bunch of pdfs in it/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer ['Rel_22122021', 'Rel_01082022', 'Rel_01092022', 'Rel_13012022', 'Rel_01122021', 'Rel_30122021', 'Rel_24032022', 'Rel_02052022', 'Rel_01032022', 'court_documents', 'Rel_18012022', 'Rel_01042022', 'Rel_01112022', 'Rel_01072022', 'Rel_13122021', 'Rel_03102022', 'Rel_01062022'] []\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_22122021 [] ['Supplemental-Index-12-22-21.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022 [] ['125742_S2_M5_54_ezeanolue-e-2019.pdf', 'FDA-CBER-2021-5683-0396196_125742_S1_M5_bnt162-01-S-D-supppe.xpt', 'FDA-CBER-2021-5683-0396193 to -0396194_125742_S1_M5_c4591001-S-D-supppe.xpt', 'FDA-CBER-2021-5683-0396187_125742_S1_M5_c4591001-S-D-pr.xpt', 'FDA-CBER-2021-5683-0396188 to -0396192_125742_S1_M5_c4591001-S-D-suppmo.xpt', 'FDA-CBER-2021-5683-0308157 to -0396186_125742_S1_M5_c4591001-S-D-suppface.xpt', 'FDA-CBER-2021-5683-0396197_125742_S1_M5_bnt162-01-S-D-supprp.xpt', 'FDA-CBER-2021-5683-0396198_125742_S1_M5_bnt162-01-S-D-te.xpt', 'FDA-CBER-2021-5683-0396195_125742_S1_M5_bnt162-01-S-D-relrec.xpt', 'FDA-CBER-2021-5683-0396199_125742_S1_M5_bnt162-01-S-D-tv.xpt']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022 [] ['FDA-CBER-2021-5683-0396228-0396233_125742_S1_M5_bnt162-01-S-D-rp.xpt', 'FDA-CBER-2021-5683-0396239-0396241_125742_S1_M5_bnt162-01-S-D-suppeg.xpt', 'FDA-CBER-2021-5683-0396249-0396254_125742_S1_M5_bnt162-01-S-D-xb.xpt', 'FDA-CBER-2021-5683-0396242-0396246_125742_S1_M5_bnt162-01-S-D-suppxa.xpt', 'FDA-CBER-2021-5683-0396255-0484341_125742_S1_M5_c4591001-S-Supp-D-suppface.xpt', 'FDA-CBER-2021-5683-0396247-0396248_125742_S1_M5_bnt162-01-S-D-ta.xpt', 'FDA-CBER-2021-5683-0396234-0396238_125742_S1_M5_bnt162-01-S-D-suppdv.xpt', 'FDA-CBER-2021-5683-0396200-0396213_125742_S1_M5_bnt162-01-A-D-adae.xpt', 'FDA-CBER-2021-5683-0396223-0396227_125742_S1_M5_bnt162-01-S-D-dv.xpt', 'FDA-CBER-2021-5683-0396214-0396222_125742_S1_M5_bnt162-01-S-D-cm.xpt']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13012022 [] ['CRFs-for-site-1128.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01122021 [] ['Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf', 'Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_30122021 [] ['CRFs-for-site-1081.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_24032022 [] ['125742_S1_M1_priority-review-request.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022 [] ['FDA-CBER-2021-5683-0058316 to -0058458_125742_S1_M5_c4591001-A-Supp-define.xml', 'FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt', 'FDA-CBER-2021-5683-0123168 to -0126026_125742_S1_M5_c4591001-A-D-adva.xpt', '125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf', '125742_S1_M5_CRF_c4591001-1006-10061020.pdf', '125742_S1_M5_CRF_c4591001-1001-10011100.pdf', '125742_S1_M5_CRF_c4591001-1003-10031197.pdf', '125742_S1_M5_bnt162-01-S-csdrg.pdf', '125742_S1_M5_5351_bnt162-01-interim3-sap.pdf', '125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf', '125742_S1_M5_CRF_c4591001-1003-10031186.pdf', '125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf', 'FDA-CBER-2021-5683-0058676 to -0058794_125742_S1_M5_bnt162-01-A-define.xml', 'FDA-CBER-2021-5683-0058795 to -0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl', '125742_S1_M5_5351_bnt162-01_20242.pdf', '125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf', '125742_S1_M5_c4591001-S-Supp-acrf.pdf', '125742_S1_M5_CRF_c4591001-1005-10051214.pdf', '125742_S1_M5_CRF_c4591001-1006-10061094.pdf', '125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf', '125742_S1_M5_CRF_c4591001-1005-10051411.pdf', '125742_S1_M5_CRF_c4591001-1006-10061040.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf', '125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf', 'FDA-CBER-2021-5683-0058829 to -0058954_125742_S1_M5_bnt162-01-S-define.xml', 'FDA-CBER-2021-5683-0065774 to -0066700_125742_S1_M5_c4591001-A-D-addv.xpt', '125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf', '125742_S1_M5_CRF_c4591001-1006-10061052.pdf', 'FDA-CBER-2021-5683-0058955 to -0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl', 'FDA-CBER-2021-5683-0058479 to -0058594_125742_S1_M5_c4591001-S-define.xml', '125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf', '125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf', '125742_S1_M5_CRF_c4591001-1003-10031113.pdf', '125742_S1_M5_CRF_c4591001-1005-10051347.pdf', 'FDA-CBER-2021-5683-0066701 to -0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt', '125742_S1_M5_5351_bnt162-01_10075.pdf', '125742_S1_M5_CRF_c4591001-1005-10051387.pdf', '125742_S1_M5_5351_bnt162-01_20215.pdf', '125742_S1_M5_CRF_c4591001-1003-10031065.pdf', '125742_S1_M5_CRF_c4591001-1006-10061098.pdf', '125742_S1_M5_c4591001-S-csdrg.pdf', '125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf', '125742_S1_M5_CRF_c4591001-1003-10031111.pdf', '125742_S1_M5_CRF_c4591001-1005-10051054.pdf', '125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf', '125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf', 'FDA-CBER-2021-5683-0058615 to -0058652_125742_S1_M5_c4591001-S-Supp-define.xml', 'FDA-CBER-2021-5683-0058653 to -0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl', '125742_S1_M5_CRF_c4591001-1001-10011135.pdf', '125742_S1_M5_5351_bnt162-01_10010.pdf', '125742_S1_M5_CRF_c4591001-1005-10051069.pdf', '125742_S1_M5_CRF_c4591001-1003-10031149.pdf', '125742_S1_M5_CRF_c4591001-1006-10061176.pdf', '125742_S1_M5_bnt162-01-A-adrg.pdf', '125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf', '125742_S1_M5_c4591001-S-acrf.pdf', '125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf', '125742_S1_M5_CRF_c4591001-1005-10051293.pdf', '125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf', '125742_S1_M5_CRF_c4591001-1003-10031038.pdf', '125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf', '125742_S1_M5_CRF_c4591001-1003-10031207.pdf', '125742_S1_M5_bnt162-01-S-acrf.pdf', '125742_S1_M5_5351_bnt162-01_20116.pdf', '125742_S1_M5_CRF_c4591001-1005-10051047.pdf', '125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf', '125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf', 'FDA-CBER-2021-5683-0058459 to -0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl', 'FDA-CBER-2021-5683-0058595 to -0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl', '125742_S1_M5_CRF_c4591001-1001-10011093.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022 [] ['125742_S1_M2_27_literature-references.pdf', 'FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx', '125742_S1_M1_priority-review-request.pdf', 'FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt', '125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf', '125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf', '125742_S1_M5_CRF_c4591001-1085-10851129.pdf', 'FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx', '125742_S1_M1_financial-cert-bias.pdf', 'FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx', '125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf', '125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf', 'FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt', 'FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx', '125742_S1_M1_cover.pdf', '125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf', '125742_S1_M5_CRF_c4591001-1085-10851116.pdf', '125742_S1_M1_userfee.pdf', '125742_S1_M2_26_pharmkin-written-summary.pdf', 'FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx', '125742_S1_M5_c4591001-T-S-suppl-arg.pdf', '125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf', '125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf', 'FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt', '125742_S1_M1_ipsp-agreed-letter.pdf', 'FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt', 'FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx', '125742_S1_M1_356h.pdf', '125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf', 'FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx', '125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf', 'FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt', 'FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt', 'FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt', 'FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx', 'FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx', '125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf', 'FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt', '125742_S1_M1_us-agent-authorization.pdf', '125742_S1_M5_c4591001-T-S-roadmap.pdf', '125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf', '125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf', '125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf', 'FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt', 'FDA-CBER-2021-5683-0023150 to -0023454_125742_S1_M5_c4591001-A-define.xml', '125742_S1_M5_c4591001-A-report-cci-dementia.pdf', '125742_S1_M5_c4591001-A-report-cci-renal.pdf', '125742_S1_M5_c4591001-A-comorbidity-categories.pdf', '125742_S1_M5_CRF_c4591001-1085-10851216.pdf', '125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf', 'FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx', '125742_S1_M5_c4591001-A-report-cci-mi.pdf', '125742_S1_M1_financial-cert-3454.pdf', '125742_S1_M4_4223_R-20-0072.pdf', 'FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx', 'FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx', 'FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt', '125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf', '125742_S1_M5_c4591001-A-report-cci-leukemia.pdf', '125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf', 'FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx', 'FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx', '125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf', '125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf', '125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf', '125742_S1_M5_c4591001-A-report-cci-chf.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf', 'FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx', '125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf', '125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf', '125742_S1_M4_4223_185350.pdf', '125742_S1_M1_3674.pdf', '125742_S1_M2_22_introduction.pdf', 'FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx', '125742_S1_M2_27_synopses-indiv-studies.pdf', '125742_S1_M2_24_nonclinical-overview.pdf', '125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf', 'FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx', 'FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt', 'FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx', 'FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx', 'FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx', 'FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt', '125742_S1_M1_fast-track-designation.pdf', 'FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt', '125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf', 'FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx', 'FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt', '125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf', '125742_S1_M5_CRF_c4591001-1085-10851018.pdf', '125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf', 'FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt', 'FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt', 'FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt', '125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf', '125742_S1_M5_5351_c4591001-fa-interim-errata.pdf', '125742_S1_M1_waiver-req-designated-suffix.pdf', 'FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx', '125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf', 'FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx', '125742_S1_M1_debarment.pdf', 'FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt', '125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf', 'FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl', '125742_S1_M5_c4591001-A-adrg.pdf', '125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf', 'FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt', 'FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt', '125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf', '125742_S1_M1_trans-of-oblig.pdf', 'FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt', 'FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx', '125742_S1_M2_26_pharmkin-tabulated-summary.pdf', '125742_S1_M1_exclusivity-claim.pdf', 'FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt', 'FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt', '125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf', '125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf', 'FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx', 'FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt', 'FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx', '125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf', '125742_S1_M5_CRF_c4591001-1085-10851246.pdf', 'FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents [] ['056-ORDER-GRANTING-IN-PART-THE-MOTION-TO-MODIFY-THE-PRODUCTION-SCHEDULE-AND-ADDOPTS-THE-JOINT-STATUS-REPORT-MODIFIED-AGREED-PRODUCTION-SCHEDULE.pdf', '037-Brief-Memorandum-in-Support-filed-by-FDA-re-36-MOTION-To-Partially-Modify-Scheduling-Order-1.pdf', '030-FDAs-Appendix-in-Support-of-Brief.pdf', '023-FDA-Appendix-in-Support-1.pdf', '031-REPLY-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-22-Brief-Memorandum-in-Support-of-Motion.pdf', '041-Memorandum-in-Support-filed-by-Pfizer-Inc.-re-40-MOTION-to-Intervene-for-a-Limited-Purpose.pdf', '038-Appendix-in-Support-filed-by-FDA-re-36-MOTION-To-Partially-Modify-Scheduling-Order.pdf', '032-Appendix-in-Support-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-31-Reply.pdf', '022-FDA-Brief-in-Advance-of-Scheduling-Conference.pdf', 'Order-February-7-2022.pdf', '044-PL-PHPMTS-MOL-IN-OPPOSITION-TO-DEFENDANTS-MOTION-TO-MODIFY-THE-SCHEDULING-ORDER-OF-THE-COURT.pdf', '091621-Complaint.pdf', '111521-Second-Joint-Status-Report.pdf', '027-Appendix-in-Support-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-26-Brief-Memorandum-in-Support-of-Motion.pdf', '034-Transcript-of-Scheduling-Conference-December-14-2021.pdf', 'ORDER_2022_01_06.pdf', '047-PLAINTIFFS-RESPONSE-TO-PFIZER-INC.S-MOTION-FOR-LEAVE-TO-INTERVENE-FOR-A-LIMITED-PURPOSE.pdf', '029-FDAs-Reply-re-Brief-in-Support-of-Motion.pdf', '026-Brief-Memorandum-in-Support-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-21-Order-Setting-DeadlineHearing.pdf', '046-RESPONSE-filed-by-Food-and-Drug-Administration-re-40-MOTION-to-Intervene-for-a-Limited-Purpose.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_18012022 [] ['CRFs-for-site-1096.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022 [] ['125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf', '125742_S1_M5_5351_c4591001-fa-interim-publications.pdf', '125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdf', '125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdf', 'reissue_5.3.6 postmarketing experience.pdf', '125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdf', '125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdf', '125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdf', '125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdf', '125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdf', '125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdf', '125742_S1_M5_5351_c4591001-fa-interim-randomization.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022 [] ['FDA-CBER-2021-5683-0593482-0593595-125742_S1_M5_bnt162-01-S-D-pe.xpt', 'FDA-CBER-2021-5683-0593327-0593481-125742_S1_M5_bnt162-01-S-D-ce.xpt', 'FDA-CBER-2021-5683-0539816-0593326-125742_S1_M5_c4591001-01-S-Supp-D-face.xpt', 'FDA-CBER-2021-5683-0593596-0593620-125742_S1_M5_bnt162-01-S-D-se.xpt', 'FDA-CBER-2021-5683-0593621-0593664-125742_S1_M5_bnt162-01-S-Supp-D-suppae.xpt', 'FDA-CBER-2021-5683-0593665-0593743-125742_S1_M5_bnt162-01-S-Supp-D-suppcm.xpt', 'FDA-CBER-2021-5683-0593770-0593800-125742_S1_M5_bnt162-01-S-Supp-D-suppec.xpt', 'FDA-CBER-2021-5683-0593801-0593831-125742_S1_M5_bnt162-01-S-Supp-D-suppex.xpt', '125742_S1_M4_20256434.pdf', 'FDA-CBER-2021-5683-0593744-0593769-125742_S1_M5_bnt162-01-S-Supp-D-suppds.xpt']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022 [] ['125742_S2_M1_com195lpus-carton-puurs.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-compliance-sensitive.pdf', '125742_S2_M1_comvlabkz-vial-kzoo.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.pdf', 'FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.xpt', '125742_S2_M1_comvlabp-vial-puurs.pdf', '125742_S1_M5_5351_c4591001-fa-interim-sap.pdf', 'FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.xpt', '125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf', '125742_S2_M1_right-of-reference.pdf', '125742_S2_M1_loa-dmf-031786-vials.pdf', 'FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.xpt', '125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-protocol-deviations.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients-sensitive.pdf', '125742_S2_M1_fk-diluent-carton.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf', '125742_S2_M1_hospira-diluent-label.pdf', '125742_S2_M1_loa-dmf-011321-vials.pdf', '125742_S2_M1_loa-dmf-012683-vials.pdf', '125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf', '125742_S2_M1_fk-diluent-stamp.pdf', 'FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.xpt', 'FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.xpt', '125742_S1_M5_5351_c4591001-interim-mth6-efficacy-response.pdf', '125742_S2_M5_5354_wi235284-protocol.pdf', '125742_S2_M1_loa-dmf-011793-vials.pdf', 'FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.xpt', '125742_S2_M1_hospira-diluent-carton.pdf', 'FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.xpt', '125742_S1_M5_5351_c4591001-interim-mth6-errata.pdf', '125742_S2_M1_com195lkz-carton-kzoo.pdf', '125742_S2_M1_loa-dmf-10953-stopper.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-sap.pdf', '125742_S2_M1_com25ctkz-carton-kzoo.pdf', '125742_S2_M1_com25ctpus-carton-puurs.pdf', 'FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.xpt', '125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients.pdf', 'FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.xpt', 'FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.xpt', '125742_S2_M1_loa-dmf-011820-vials.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021 [] ['STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf', 'BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt', 'STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf', 'STN-125742_0_0-Section-2.5-Clinical-Overview.pdf', 'BATES-FDA-CBER-2021-5683-0002376_relrec.xpt', 'BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt', 'BATES-FDA-CBER-2021-5683-0002377_supppr.xpt', 'BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt', 'CRFs-for-site-1055.pdf', 'BATES-FDA-CBER-2021-5683-0002379_te.xpt', 'BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt', 'BATES-FDA-CBER-2021-5683-0002380_ti.xpt', 'BATES-FDA-CBER-2021-5683-0002378_ta.xpt', 'signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022 [] ['FDA-CBER-2021-5683-0484461-0537913-125742_S1_M5_c4591001-S-D-face.xpt', 'FDA-CBER-2021-5683-0484452-0484460-125742_S1_M5_bnt162-01-S-D-ti.xpt', 'FDA-CBER-2021-5683-0484442-0484451-125742_S1_M5_bnt162-01-S-D-ex.xpt', 'FDA-CBER-2021-5683-0537914-0539336-125742_S1_M5_bnt162-01-A-D-adfacevd.xpt', 'FDA-CBER-2021-5683-0484356-0484378-125742_S1_M5_bnt162-01-S-D-xa.xpt', 'FDA-CBER-2021-5683-0484419-0484441-125742_S1_M5_bnt162-01-S-D-eg.xpt', 'FDA-CBER-2021-5683-0484384-0484408-125742_S1_M5_bnt162-01-S-D-ds.xpt', 'FDA-CBER-2021-5683-0484342-0484355-125742_S1_M5_bnt162-01-S-D-ae.xpt', 'FDA-CBER-2021-5683-0484379-0484383-125742_S1_M5_bnt162-01-S-D-dm.xpt', 'FDA-CBER-2021-5683-0539337-0539815-125742_S1_M5_bnt162-01-A-D-advs.xpt', 'FDA-CBER-2021-5683-0484409-0484418-125742_S1_M5_bnt162-01-S-D-ec.xpt']\n",
      "/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022 [] ['125742_S1_M5_CRF_c4591001-1013-10131165.pdf', '125742_S1_M5_CRF_c4591001-1015-10151047.pdf', 'FDA-CBER-2021-5683-0165893 to -0168682_125742_S1_M5_c4591001-S-D-is.xpt', '125742_S1_M5_CRF_c4591001-1081-10811194 reissue.pdf', 'FDA-CBER-2021-5683-0178319 to -0180190_125742_S1_M5_c4591001-S-D-suppho.xpt', 'FDA-CBER-2021-5683-0196049 to -0205317_125742_S1_M5_c4591001-S-Supp-D-ce.xpt', '125742_S1_M2_summary-biopharm.pdf', '125742_S1_M5_CRF_c4591001-1008-10081152.pdf', 'FDA-CBER-2021-5683-0174607 to -0178318_125742_S1_M5_c4591001-S-D-suppdv.xpt', '125742_S1_M5_CRF_c4591001-1008-10081184.pdf', '125742_S1_M5_CRF_c4591001-1013-10131229.pdf', '125742_S1_M5_CRF_c4591001-1007-10071192.pdf', '125742_S1_M5_CRF_c4591001-1007-10071347.pdf', '125742_S1_M5_CRF_c4591001-1015-10151134.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-patient-batches.pdf', 'FDA-CBER-2021-5683-0159487 to -0162689_125742_S1_M5_c4591001-S-D-ec.xpt', '125742_S1_M5_CRF_c4591001-1013-10131176.pdf', '125742_S1_M5_5351_c4591001-fa-interim-discontinued-patients.pdf', 'FDA-CBER-2021-5683-0158560 to -0159486_125742_S1_M5_c4591001-S-D-dv.xpt', '125742_S1_M5_CRF_c4591001-1012-10121163.pdf', 'FDA-CBER-2021-5683-0208521 to -0216666_125742_S1_M5_c4591001-S-Supp-D-suppvs.xpt', '125742_S1_M5_CRF_c4591001-1007-10071097.pdf', 'FDA-CBER-2021-5683-0168683 to -0169081_125742_S1_M5_c4591001-S-D-suppcm.xpt', '125742_S1_M5_CRF_c4591001-1013-10131517.pdf', '125742_S1_M5_CRF_c4591001-1007-10071280.pdf', '125742_S1_M5_CRF_c4591001-1128-11281009 reissue.pdf', '125742_S1_M5_CRF_c4591001-1015-10151225.pdf', 'FDA-CBER-2021-5683-0149082 to -0158559_125742_S1_M5_c4591001-S-D-ce.xpt', '125742_S1_M5_CRF_c4591001-1012-10121112.pdf', '125742_S1_M5_5351_c4591001-fa-interim-patient-batches.pdf', '125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations-sensitive.pdf', '125742_S1_M5_CRF_c4591001-1013-10131699.pdf', '125742_S1_M5_CRF_c4591001-1011-10111181.pdf', '125742_S1_M5_CRF_c4591001-1007-10071443.pdf', '125742_S1_M5_CRF_c4591001-1009-10091123.pdf', '125742_S1_M5_CRF_c4591001-1008-10081337.pdf', '125742_S1_M5_CRF_c4591001-1015-10151035.pdf', '125742_S1_M5_CRF_c4591001-1009-10091135.pdf', '125742_S1_M5_CRF_c4591001-1007-10071441.pdf', '125742_S1_M5_CRF_c4591001-1013-10131089.pdf', '125742_S1_M5_CRF_c4591001-1008-10081056.pdf', '125742_S1_M5_CRF_c4591001-1007-10071124.pdf', '125742_S1_M5_CRF_c4591001-1007-10071050.pdf', '125742_S1_M5_CRF_c4591001-1013-10131658.pdf', '125742_S1_M5_CRF_c4591001-1015-10151011.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-randomization.pdf', '125742_S1_M5_CRF_c4591001-1007-10071101.pdf', '125742_S1_M5_CRF_c4591001-1013-10131084.pdf', '125742_S1_M5_CRF_c4591001-1007-10071276.pdf', 'FDA-CBER-2021-5683-0171524 to -0174606_125742_S1_M5_c4591001-S-D-suppds.xpt', '125742_S1_M5_CRF_c4591001-1013-10131656.pdf', '125742_S1_M5_CRF_c4591001-1015-10151238.pdf', '125742_S1_M5_CRF_c4591001-1007-10071315.pdf', '125742_S1_M5_CRF_c4591001-1007-10071117.pdf', '125742_S1_M5_CRF_c4591001-1008-10081667.pdf', '125742_S1_M5_CRF_c4591001-1013-10131653.pdf', '125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf', 'FDA-CBER-2021-5683-0180191 to -0182980_125742_S1_M5_c4591001-S-D-suppis.xpt', '125742_S1_M5_CRF_c4591001-1012-10121097.pdf', 'STN 125742-0-0 Section 2.5 Clinical Overview reissue.pdf', '125742_S1_M5_CRF_c4591001-1013-10131718.pdf', '125742_S1_M5_CRF_c4591001-1009-10091128.pdf', '125742_S1_M5_CRF_c4591001-1007-10071306.pdf', '125742_S1_M5_CRF_c4591001-1013-10131255.pdf', 'FDA-CBER-2021-5683-0162690 to -0165892_125742_S1_M5_c4591001-S-D-ex.xpt', '125742_S1_M5_CRF_c4591001-1011-10111029.pdf', '125742_S1_M5_CRF_c4591001-1013-10131554.pdf', '125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf', 'FDA-CBER-2021-5683-0182981 to -0187905_125742_S1_M5_c4591001-S-D-suppmh.xpt', '125742_S1_M5_CRF_c4591001-1008-10081603.pdf', '125742_S1_M5_CRF_c4591001-1015-10151071.pdf', '125742_S1_M5_CRF_c4591001-1013-10131190.pdf', '125742_S1_M5_CRF_c4591001-1013-10131386.pdf', '125742_S1_M5_5314_shi-sop-10011.pdf', '125742_S1_M5_CRF_c4591001-1008-10081628.pdf', '125742_S1_M5_CRF_c4591001-1013-10131786.pdf', '125742_S1_M5_CRF_c4591001-1015-10151101.pdf', '125742_S1_M5_CRF_c4591001-1009-10091149.pdf', '125742_S1_M5_CRF_c4591001-1007-10071159.pdf', 'FDA-CBER-2021-5683-0169082 to -0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt', 'FDA-CBER-2021-5683-0187906 to -0196048_125742_S1_M5_c4591001-S-D-suppvs.xpt', 'FDA-CBER-2021-5683-0205318 to -0208520_125742_S1_M5_c4591001-S-Supp-D-ex.xpt', 'FDA-CBER-2021-5683-0142307 to -0149081_125742_S1_M5_c4591001-A-Supp-D-adcevd.xpt', '125742_S1_M5_CRF_c4591001-1015-10151089.pdf']\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_22122021/Supplemental-Index-12-22-21.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/125742_S2_M5_54_ezeanolue-e-2019.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396196_125742_S1_M5_bnt162-01-S-D-supppe.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396193 to -0396194_125742_S1_M5_c4591001-S-D-supppe.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396187_125742_S1_M5_c4591001-S-D-pr.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396188 to -0396192_125742_S1_M5_c4591001-S-D-suppmo.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0308157 to -0396186_125742_S1_M5_c4591001-S-D-suppface.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396197_125742_S1_M5_bnt162-01-S-D-supprp.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396198_125742_S1_M5_bnt162-01-S-D-te.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396195_125742_S1_M5_bnt162-01-S-D-relrec.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01082022/FDA-CBER-2021-5683-0396199_125742_S1_M5_bnt162-01-S-D-tv.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396228-0396233_125742_S1_M5_bnt162-01-S-D-rp.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396239-0396241_125742_S1_M5_bnt162-01-S-D-suppeg.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396249-0396254_125742_S1_M5_bnt162-01-S-D-xb.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396242-0396246_125742_S1_M5_bnt162-01-S-D-suppxa.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396255-0484341_125742_S1_M5_c4591001-S-Supp-D-suppface.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396247-0396248_125742_S1_M5_bnt162-01-S-D-ta.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396234-0396238_125742_S1_M5_bnt162-01-S-D-suppdv.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396200-0396213_125742_S1_M5_bnt162-01-A-D-adae.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396223-0396227_125742_S1_M5_bnt162-01-S-D-dv.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01092022/FDA-CBER-2021-5683-0396214-0396222_125742_S1_M5_bnt162-01-S-D-cm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13012022/CRFs-for-site-1128.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01122021/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01122021/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_30122021/CRFs-for-site-1081.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_24032022/125742_S1_M1_priority-review-request.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058316 to -0058458_125742_S1_M5_c4591001-A-Supp-define.xml',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0123168 to -0126026_125742_S1_M5_c4591001-A-D-adva.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1006-10061020.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1001-10011100.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031197.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_bnt162-01-S-csdrg.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-sap.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031186.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058676 to -0058794_125742_S1_M5_bnt162-01-A-define.xml',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058795 to -0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01_20242.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_c4591001-S-Supp-acrf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051214.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1006-10061094.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051411.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1006-10061040.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058829 to -0058954_125742_S1_M5_bnt162-01-S-define.xml',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0065774 to -0066700_125742_S1_M5_c4591001-A-D-addv.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1006-10061052.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058955 to -0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058479 to -0058594_125742_S1_M5_c4591001-S-define.xml',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031113.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051347.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0066701 to -0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01_10075.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051387.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01_20215.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031065.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1006-10061098.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_c4591001-S-csdrg.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031111.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051054.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058615 to -0058652_125742_S1_M5_c4591001-S-Supp-define.xml',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058653 to -0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1001-10011135.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01_10010.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051069.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031149.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1006-10061176.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_bnt162-01-A-adrg.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_c4591001-S-acrf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051293.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031038.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1003-10031207.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_bnt162-01-S-acrf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01_20116.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1005-10051047.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058459 to -0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/FDA-CBER-2021-5683-0058595 to -0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_02052022/125742_S1_M5_CRF_c4591001-1001-10011093.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M2_27_literature-references.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_priority-review-request.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_CRF_c4591001-1085-10851129.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_financial-cert-bias.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_cover.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_CRF_c4591001-1085-10851116.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_userfee.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M2_26_pharmkin-written-summary.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-T-S-suppl-arg.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_ipsp-agreed-letter.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_356h.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_us-agent-authorization.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-T-S-roadmap.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023150 to -0023454_125742_S1_M5_c4591001-A-define.xml',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-dementia.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-renal.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-comorbidity-categories.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_CRF_c4591001-1085-10851216.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-mi.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_financial-cert-3454.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M4_4223_R-20-0072.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-leukemia.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-chf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M4_4223_185350.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_3674.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M2_22_introduction.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M2_27_synopses-indiv-studies.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M2_24_nonclinical-overview.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_fast-track-designation.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_CRF_c4591001-1085-10851018.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-errata.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_waiver-req-designated-suffix.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_debarment.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-adrg.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_trans-of-oblig.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M2_26_pharmkin-tabulated-summary.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M1_exclusivity-claim.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/125742_S1_M5_CRF_c4591001-1085-10851246.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01032022/FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/056-ORDER-GRANTING-IN-PART-THE-MOTION-TO-MODIFY-THE-PRODUCTION-SCHEDULE-AND-ADDOPTS-THE-JOINT-STATUS-REPORT-MODIFIED-AGREED-PRODUCTION-SCHEDULE.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/037-Brief-Memorandum-in-Support-filed-by-FDA-re-36-MOTION-To-Partially-Modify-Scheduling-Order-1.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/030-FDAs-Appendix-in-Support-of-Brief.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/023-FDA-Appendix-in-Support-1.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/031-REPLY-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-22-Brief-Memorandum-in-Support-of-Motion.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/041-Memorandum-in-Support-filed-by-Pfizer-Inc.-re-40-MOTION-to-Intervene-for-a-Limited-Purpose.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/038-Appendix-in-Support-filed-by-FDA-re-36-MOTION-To-Partially-Modify-Scheduling-Order.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/032-Appendix-in-Support-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-31-Reply.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/022-FDA-Brief-in-Advance-of-Scheduling-Conference.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/Order-February-7-2022.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/044-PL-PHPMTS-MOL-IN-OPPOSITION-TO-DEFENDANTS-MOTION-TO-MODIFY-THE-SCHEDULING-ORDER-OF-THE-COURT.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/091621-Complaint.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/111521-Second-Joint-Status-Report.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/027-Appendix-in-Support-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-26-Brief-Memorandum-in-Support-of-Motion.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/034-Transcript-of-Scheduling-Conference-December-14-2021.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/ORDER_2022_01_06.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/047-PLAINTIFFS-RESPONSE-TO-PFIZER-INC.S-MOTION-FOR-LEAVE-TO-INTERVENE-FOR-A-LIMITED-PURPOSE.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/029-FDAs-Reply-re-Brief-in-Support-of-Motion.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/026-Brief-Memorandum-in-Support-filed-by-Public-Health-and-Medical-Professionals-for-Transparency-re-21-Order-Setting-DeadlineHearing.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/court_documents/046-RESPONSE-filed-by-Food-and-Drug-Administration-re-40-MOTION-to-Intervene-for-a-Limited-Purpose.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_18012022/CRFs-for-site-1096.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-publications.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/reissue_5.3.6 postmarketing experience.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01042022/125742_S1_M5_5351_c4591001-fa-interim-randomization.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593482-0593595-125742_S1_M5_bnt162-01-S-D-pe.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593327-0593481-125742_S1_M5_bnt162-01-S-D-ce.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0539816-0593326-125742_S1_M5_c4591001-01-S-Supp-D-face.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593596-0593620-125742_S1_M5_bnt162-01-S-D-se.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593621-0593664-125742_S1_M5_bnt162-01-S-Supp-D-suppae.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593665-0593743-125742_S1_M5_bnt162-01-S-Supp-D-suppcm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593770-0593800-125742_S1_M5_bnt162-01-S-Supp-D-suppec.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593801-0593831-125742_S1_M5_bnt162-01-S-Supp-D-suppex.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/125742_S1_M4_20256434.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01112022/FDA-CBER-2021-5683-0593744-0593769-125742_S1_M5_bnt162-01-S-Supp-D-suppds.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_com195lpus-carton-puurs.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-compliance-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_comvlabkz-vial-kzoo.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_comvlabp-vial-puurs.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-fa-interim-sap.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_right-of-reference.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_loa-dmf-031786-vials.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-protocol-deviations.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_fk-diluent-carton.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_hospira-diluent-label.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_loa-dmf-011321-vials.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_loa-dmf-012683-vials.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_fk-diluent-stamp.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-efficacy-response.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M5_5354_wi235284-protocol.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_loa-dmf-011793-vials.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_hospira-diluent-carton.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-errata.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_com195lkz-carton-kzoo.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_loa-dmf-10953-stopper.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-sap.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_com25ctkz-carton-kzoo.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_com25ctpus-carton-puurs.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01072022/125742_S2_M1_loa-dmf-011820-vials.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/STN-125742_0_0-Section-2.5-Clinical-Overview.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002376_relrec.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002377_supppr.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/CRFs-for-site-1055.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002379_te.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002380_ti.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/BATES-FDA-CBER-2021-5683-0002378_ta.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_13122021/signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484461-0537913-125742_S1_M5_c4591001-S-D-face.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484452-0484460-125742_S1_M5_bnt162-01-S-D-ti.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484442-0484451-125742_S1_M5_bnt162-01-S-D-ex.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0537914-0539336-125742_S1_M5_bnt162-01-A-D-adfacevd.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484356-0484378-125742_S1_M5_bnt162-01-S-D-xa.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484419-0484441-125742_S1_M5_bnt162-01-S-D-eg.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484384-0484408-125742_S1_M5_bnt162-01-S-D-ds.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484342-0484355-125742_S1_M5_bnt162-01-S-D-ae.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484379-0484383-125742_S1_M5_bnt162-01-S-D-dm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0539337-0539815-125742_S1_M5_bnt162-01-A-D-advs.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_03102022/FDA-CBER-2021-5683-0484409-0484418-125742_S1_M5_bnt162-01-S-D-ec.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131165.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151047.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0165893 to -0168682_125742_S1_M5_c4591001-S-D-is.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1081-10811194 reissue.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0178319 to -0180190_125742_S1_M5_c4591001-S-D-suppho.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0196049 to -0205317_125742_S1_M5_c4591001-S-Supp-D-ce.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M2_summary-biopharm.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081152.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0174607 to -0178318_125742_S1_M5_c4591001-S-D-suppdv.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081184.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131229.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071192.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071347.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151134.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-interim-mth6-patient-batches.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0159487 to -0162689_125742_S1_M5_c4591001-S-D-ec.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131176.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-fa-interim-discontinued-patients.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0158560 to -0159486_125742_S1_M5_c4591001-S-D-dv.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1012-10121163.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0208521 to -0216666_125742_S1_M5_c4591001-S-Supp-D-suppvs.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071097.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0168683 to -0169081_125742_S1_M5_c4591001-S-D-suppcm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131517.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071280.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1128-11281009 reissue.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151225.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0149082 to -0158559_125742_S1_M5_c4591001-S-D-ce.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1012-10121112.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-fa-interim-patient-batches.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations-sensitive.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131699.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1011-10111181.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071443.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1009-10091123.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081337.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151035.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1009-10091135.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071441.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131089.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081056.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071124.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071050.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131658.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151011.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-interim-mth6-randomization.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071101.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131084.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071276.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0171524 to -0174606_125742_S1_M5_c4591001-S-D-suppds.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131656.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151238.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071315.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071117.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081667.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131653.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0180191 to -0182980_125742_S1_M5_c4591001-S-D-suppis.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1012-10121097.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/STN 125742-0-0 Section 2.5 Clinical Overview reissue.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131718.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1009-10091128.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071306.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131255.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0162690 to -0165892_125742_S1_M5_c4591001-S-D-ex.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1011-10111029.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131554.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0182981 to -0187905_125742_S1_M5_c4591001-S-D-suppmh.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081603.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151071.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131190.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131386.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_5314_shi-sop-10011.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1008-10081628.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1013-10131786.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151101.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1009-10091149.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1007-10071159.pdf',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0169082 to -0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0187906 to -0196048_125742_S1_M5_c4591001-S-D-suppvs.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0205318 to -0208520_125742_S1_M5_c4591001-S-Supp-D-ex.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/FDA-CBER-2021-5683-0142307 to -0149081_125742_S1_M5_c4591001-A-Supp-D-adcevd.xpt',\n",
       " '/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer/Rel_01062022/125742_S1_M5_CRF_c4591001-1015-10151089.pdf']"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import os\n",
    "import time\n",
    "from tqdm import tqdm\n",
    "\n",
    "# Define the target directory\n",
    "root_dir = \"/Users/arihantchoudhary/GitHub/Klarity/uploads/Pfizer\"\n",
    "\n",
    "# Count total files and folders\n",
    "file_list = []\n",
    "for root, dirs, files in os.walk(root_dir):\n",
    "    print(root, dirs, files)\n",
    "    for file in files:\n",
    "        file_list.append(os.path.join(root, file))\n",
    "\n",
    "file_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files:  47%|████▋     | 198/419 [00:20<00:23,  9.46file/s]\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[4], line 4\u001b[0m\n\u001b[1;32m      2\u001b[0m start_time \u001b[38;5;241m=\u001b[39m time\u001b[38;5;241m.\u001b[39mtime()\n\u001b[1;32m      3\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m file_path \u001b[38;5;129;01min\u001b[39;00m tqdm(file_list, desc\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mProcessing files\u001b[39m\u001b[38;5;124m\"\u001b[39m, unit\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mfile\u001b[39m\u001b[38;5;124m\"\u001b[39m, dynamic_ncols\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mTrue\u001b[39;00m):\n\u001b[0;32m----> 4\u001b[0m     \u001b[43mtime\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msleep\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m0.1\u001b[39;49m\u001b[43m)\u001b[49m  \u001b[38;5;66;03m# Simulating a process (remove this in actual usage)\u001b[39;00m\n\u001b[1;32m      5\u001b[0m     \u001b[38;5;66;03m# You can add file processing logic here, e.g., reading or analyzing the files\u001b[39;00m\n\u001b[1;32m      7\u001b[0m end_time \u001b[38;5;241m=\u001b[39m time\u001b[38;5;241m.\u001b[39mtime()\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "# Track progress with tqdm\n",
    "start_time = time.time()\n",
    "for file_path in tqdm(file_list, desc=\"Processing files\", unit=\"file\", dynamic_ncols=True):\n",
    "    time.sleep(0.1)  # Simulating a process (remove this in actual usage)\n",
    "    # You can add file processing logic here, e.g., reading or analyzing the files\n",
    "\n",
    "end_time = time.time()\n",
    "print(f\"\\nProcessed {len(file_list)} files in {end_time - start_time:.2f} seconds.\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# OCR\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pytesseract\n",
    "from pdf2image import convert_from_path\n",
    "from PIL import Image\n",
    "import io\n",
    "\n",
    "# Path to the file\n",
    "file_path = \"anlaysis_essay.pdf\"\n",
    "\n",
    "# Convert PDF to images\n",
    "try:\n",
    "    images = convert_from_path(file_path)\n",
    "    \n",
    "    # Extract text from all pages\n",
    "    text = \"\"\n",
    "    for i, image in enumerate(images):\n",
    "        text += pytesseract.image_to_string(image)\n",
    "    \n",
    "    document = text\n",
    "    print(f\"Processed {len(images)} pages from {file_path}\")\n",
    "except Exception as e:\n",
    "    print(f\"Error processing PDF: {str(e)}\")\n",
    "    document = None"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Single File Processing\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Error reading file: 'utf-8' codec can't decode byte 0xd3 in position 10: invalid continuation byte\n"
     ]
    }
   ],
   "source": [
    "def read_file(file_path):\n",
    "    \"\"\"Read a file from the given path and return its contents.\"\"\"\n",
    "    try:\n",
    "        with open(file_path, 'r', encoding='utf-8') as file:\n",
    "            content = file.read()\n",
    "        return content\n",
    "    except FileNotFoundError:\n",
    "        print(f\"Error: File {file_path} not found.\")\n",
    "        return None\n",
    "    except Exception as e:\n",
    "        print(f\"Error reading file: {str(e)}\")\n",
    "        return None\n",
    "\n",
    "file_name = \"Anlaysis_Essay.pdf\"  # Replace with the file you want to read\n",
    "\n",
    "\n",
    "file_content = read_file(file_name)\n",
    "if file_content:\n",
    "    print(f\"Successfully read file: {file_name}\")\n",
    "    # Uncomment to print content (be careful with large files)\n",
    "    # print(file_content)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyError",
     "evalue": "'MISTRAL_API_KEY'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[9], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m api_key \u001b[38;5;241m=\u001b[39m \u001b[43mos\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43menviron\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mMISTRAL_API_KEY\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m]\u001b[49m\n\u001b[1;32m      2\u001b[0m model \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mmistral-large-latest\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m      4\u001b[0m client \u001b[38;5;241m=\u001b[39m Mistral(api_key\u001b[38;5;241m=\u001b[39mapi_key)\n",
      "File \u001b[0;32m~/miniconda3/envs/klarity/lib/python3.10/os.py:680\u001b[0m, in \u001b[0;36m_Environ.__getitem__\u001b[0;34m(self, key)\u001b[0m\n\u001b[1;32m    677\u001b[0m     value \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_data[\u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mencodekey(key)]\n\u001b[1;32m    678\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m:\n\u001b[1;32m    679\u001b[0m     \u001b[38;5;66;03m# raise KeyError with the original key value\u001b[39;00m\n\u001b[0;32m--> 680\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mKeyError\u001b[39;00m(key) \u001b[38;5;28;01mfrom\u001b[39;00m\u001b[38;5;250m \u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    681\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mdecodevalue(value)\n",
      "\u001b[0;31mKeyError\u001b[0m: 'MISTRAL_API_KEY'"
     ]
    }
   ],
   "source": [
    "api_key = os.environ[\"MISTRAL_API_KEY\"]\n",
    "model = \"mistral-large-latest\"\n",
    "\n",
    "client = Mistral(api_key=api_key)\n",
    "\n",
    "chat_response = client.chat.complete(\n",
    "    model= model,\n",
    "    messages = [\n",
    "        {\n",
    "            \"role\": \"user\",\n",
    "            \"content\": \"What is the best French cheese?\",\n",
    "        },\n",
    "    ]\n",
    ")\n",
    "print(chat_response.choices[0].message.content)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "klarity",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
